Pseudobulbar palsy

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Pseudobulbar palsy
Classification and external resources
ICD-9 335.23
DiseasesDB 10826
MeSH D020828

Pseudobulbar palsy is a medical condition characterised by the inability to control facial movements (such as chewing and speaking) and caused by a variety of neurological disorders. Patients experience difficulty chewing and swallowing, have increased reflexes and spasticity in tongue and the bulbar region, and demonstrate slurred speech (which is often the initial presentation of the disorder), sometimes also demonstrating uncontrolled emotional outbursts.

The condition is usually caused by the damage (bilateral degeneration) to the neurons of the brain stem, specifically to the corticobulbar tract (upper motor neuron tract to cranial nerve motor nuclei).

Causes[edit]

Pseudobulbar palsy is the result of damage of motor fibers traveling from the cerebral cortex to the lower brain stem. This damage might arise in the course of a variety of neurological conditions that involve demyelination and bilateral corticobulbar lesions. Examples include:

Pathophysiology[edit]

The proposed mechanism of pseudobulbar palsy points to the disinhibition of the motor neurons controlling laughter and crying, proposing that a reciprocal pathway exists between the cerebellum and the brain stem that adjusts laughter and crying responses, making them appropriate to context.[2] The pseudobulbar crying could also be induced by stimulation in the region of the subthalamic nucleus of the brain.[3]

Signs and symptoms[edit]

Signs and symptoms of pseudobulbar palsy include:

Diagnosis[edit]

Diagnosis of pseudobulbar palsy is based on observation of the symptoms of the condition. Tests examining jaw jerk and gag reflex can also be performed. It has been suggested that the majority of patients with pathological laughter and crying have pseudobulbar palsy due to bilateral corticobulbar lesions and often a bipyrimidal involvement of arms and legs.[5] To further confirm the condition, MRI can be performed to define the areas of brain abnormality.

Treatment[edit]

Since pseudobulbar palsy is a syndrome associated with other diseases, treating the underlying disease may eventually reduce the symptoms of pseudobulbar palsy.

Possible pharmacological interventions for pseudobulbar affect include the tricyclic antidepressants, serotonin reuptake inhibitors, and a novel approach utilizing dextromethorphan and quinidine sulfate. Nuedexta is an FDA approved medication for pseudobulbar affect. Dextromethorphan, an N-methyl-D-aspartate receptor antagonist, inhibits glutamatergic transmission in the regions of the brainstem and cerebellum, which are hypothesized to be involved in pseudobulbar symptoms, and acts as a sigma ligand, binding to the sigma-1 receptors that mediate the emotional motor expression.[2]

References[edit]

  1. ^ Bourgouin PM, Chalk C, Richardson J, Duang H, Vezina JL (Aug 1995). "Subcortical white matter lesions in osmotic demyelination syndrome". American Journal of Neuroradiology 16 (7): 1495–7. PMID 7484639. ]
  2. ^ a b Graham, K., Spiegel, D. "Pseudobulbar Palsy and Affect in a Case of Progressive Multifocal Leukoencephalopathy" J Neuropsychiatry Clin Neurosci 20:1, Winter 2008
  3. ^ Okun, M., Raju, D., Walter, B., Juncos, J., DeLong, M., Heilman, K., McDonald, W., Vitek, J. "Pseudobulbar crying induced by stimulation in the region of the subthalamic nucleus". J Neurol Neurosurg Psychiatry 2004;75:921–923.
  4. ^ McCormick WE, Lee JH (May 2002). "Pseudobulbar palsy caused by a large petroclival meningioma: report of two cases". Skull Base 12 (2): 067–072. doi:10.1055/s-2002-31568-1. PMC 1656925. PMID 17167648. 
  5. ^ Asfora, W., Desalles, A., ABE, M., Kjellberg, R. "Is the syndrome of pathological laughing and crying a manifestation of pseudobulbar palsy?" Journal of Neurology, Neurosurgery, and Psychiatry 1989;52:523-525

See also[edit]

External links[edit]